Vaping to Quit Smoking: Does It Actually Work?

The short answer is yes, with caveats. The long answer involves one of the most heated debates in public health, two countries taking nearly opposite approaches, and a pile of evidence that keeps growing. Let me walk through all of it so you can make an informed decision.

What the Clinical Trials Say

Let’s start with the hardest evidence we have: randomized controlled trials.

The landmark UK trial (Hajek et al., 2019, NEJM). This is the study that changed the conversation. Nearly 900 smokers were randomly assigned to either e-cigarettes or traditional NRT (their choice of patches, gum, lozenges, etc.). After one year:

18% of the e-cigarette group had quit smoking.
9.9% of the NRT group had quit smoking.

E-cigarettes were nearly twice as effective as traditional NRT. That’s a massive difference in cessation research, where improvements of a few percentage points are considered significant.

However, 80% of the successful quitters in the e-cigarette group were still vaping at the one-year mark. Only 9% of successful quitters in the NRT group were still using NRT. This is a key data point that bothers some researchers and we’ll come back to it.

The Cochrane Review. The Cochrane Collaboration, which is essentially the gold standard for systematic evidence review, has evaluated e-cigarettes for smoking cessation multiple times. Their reviews have consistently found “high-certainty evidence” that e-cigarettes with nicotine help more people quit smoking than traditional NRT. Their most recent update included data from over 80 studies.

The EAGLES trial extension and other studies. Additional trials have generally supported the finding that vaping outperforms NRT, though effect sizes vary. Some studies show more modest advantages, particularly when the comparison is NRT with behavioral support versus vaping with behavioral support.

Real-world observational data. Population studies have found that smokers who use e-cigarettes with the intention to quit and who use them daily are significantly more likely to succeed than those using other methods or nothing. The key qualifiers there are “intention to quit” and “daily use.” Casual or dual use (vaping and still smoking) is associated with worse outcomes.

The general picture from the evidence: vaping is one of the most effective cessation tools available, comparable to or better than traditional NRT, though probably not as effective as varenicline (Chantix) for the average smoker.

The UK Approach: Full Embrace

The United Kingdom has taken the most pro-vaping stance of any major country, and they’ve been at it for over a decade.

Public Health England (now the Office for Health Improvement and Disparities) published a landmark review in 2015 concluding that e-cigarettes are approximately 95% less harmful than smoking. They’ve reaffirmed this position repeatedly.

The NHS actively recommends vaping as a quit tool. If you visit an NHS stop smoking service in England, they may literally hand you a vape starter kit. In 2023, the UK government launched a “swap to stop” program providing free vape kits to a million smokers. The NHS website explicitly states: “Nicotine vaping is substantially less harmful than smoking. It’s also one of the most effective tools for quitting smoking.”

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has worked toward approving e-cigarettes as licensed medicines, which would put them alongside NRT products with official medical endorsement.

The UK’s reasoning is straightforward: smoking kills. Vaping is much less harmful. If vaping helps people quit smoking, the net public health benefit is enormous. They prioritize pragmatic harm reduction over theoretical concerns.

The results speak for themselves. UK smoking rates have fallen dramatically, from about 20% of adults in 2010 to around 12% by 2024. Vaping is credited as a major contributor to this decline. The UK has some of the lowest smoking rates in Europe.

The US Approach: Deep Suspicion

The United States takes a very different approach, and it drives a lot of confusion.

The FDA has been skeptical to hostile toward vaping as cessation. While they’ve authorized some e-cigarettes (JUUL, Vuse, NJOY) to remain on the market, the authorization is based on the products being “appropriate for the protection of public health,” not on cessation efficacy. The FDA has not approved any e-cigarette as a smoking cessation aid.

The CDC and most US medical organizations warn against vaping. The American Lung Association, American Cancer Society, and American Heart Association all take cautious-to-negative stances on vaping for cessation. Their concerns include youth uptake, unknown long-term risks, and the potential for dual use.

The 2019 EVALI outbreak damaged vaping’s reputation in the US enormously. Thousands of cases of lung injury were initially attributed to vaping generally, causing widespread panic. It was later determined that the cause was vitamin E acetate in illicit THC cartridges, not commercial nicotine e-cigarettes. But the reputational damage stuck. Many Americans still believe that legal nicotine vapes caused those injuries.

Why the US and UK disagree. Several factors drive this:

The US has a more litigious culture and regulators are more risk-averse.
The youth vaping “epidemic” hit the US harder (or was perceived to), making any pro-vaping message politically difficult.
US anti-tobacco organizations built their identity around opposing all nicotine products, making it culturally difficult to endorse one.
The US has a strong abstinence-oriented tradition in addiction treatment, while the UK leans more toward harm reduction.
Tobacco settlement money in the US created financial incentives tied to reducing all tobacco and nicotine use, not just smoking.

The science is the same in both countries. The policy interpretation is different.

What About the Harm?

Let’s be clear about what vaping does and doesn’t do to your body.

What vaping eliminates compared to smoking:

Combustion products (tar, carbon monoxide, particulate matter)
The vast majority of the 7,000+ chemicals in cigarette smoke
The 70+ known carcinogens in cigarette smoke
Secondhand smoke exposure to those around you

What vaping still involves:

Nicotine (addictive, stimulant effects on cardiovascular system)
Propylene glycol and vegetable glycerin vapor (generally recognized as safe for ingestion, but long-term inhalation effects not fully characterized)
Flavoring chemicals (some raise concerns about inhalation safety, particularly diacetyl, though most reputable brands have removed it)
Fine and ultrafine particles that enter the lungs

What the evidence shows about vaping harm:

Biomarker studies consistently show that smokers who switch completely to vaping see dramatic improvements in markers of cardiovascular and respiratory health, often approaching the levels of non-smokers within months.
A long-term UK study found that smokers who switched to vaping for two years showed no sign of increased lung damage compared to non-smokers and significant improvement compared to their smoking baseline.
There is currently no evidence of vaping causing cancer in humans, though long-term data is still accumulating.
Vaping does cause some airway irritation and may trigger coughing, sore throat, and dry mouth, particularly when starting.

The honest summary: vaping is not risk-free, but it’s dramatically less harmful than smoking by every measure we can currently assess. The Royal College of Physicians estimates the long-term risk at less than 5% of smoking’s risk.

Success Rates in Context

Let me put vaping cessation rates alongside other methods so you can see where things stand.

Cold turkey: 3-5% at one year
Nicotine patch alone: 7-10%
Nicotine gum alone: 7-10%
Combination NRT (patch + gum/lozenge): 15-20%
Bupropion (Zyban/Wellbutrin): 15-20%
Varenicline (Chantix): 20-25%
Vaping (from clinical trials): 18-20%
Vaping + behavioral support: potentially higher, though data is still emerging

These numbers all look low, and that’s because quitting smoking is genuinely hard. A 20% success rate at one year is actually among the best outcomes available. And remember, most people who eventually quit successfully have made multiple prior attempts. Each attempt teaches you something.

The Dual Use Problem

Here’s where I need to give you a real warning. The benefits of vaping for cessation only materialize if you actually stop smoking. Using both cigarettes and a vape, which is called “dual use,” gives you minimal health benefits.

Even a few cigarettes a day cause a disproportionate amount of harm. Smoking 1-4 cigarettes daily still carries roughly half the cardiovascular risk of a pack a day. The dose-response curve for smoking harm is steep at the low end.

If you’re going to try vaping to quit, you need to commit to actually replacing cigarettes, not supplementing them. Set a quit date. Switch fully. If you have a slip and smoke a cigarette, get back to vaping only as quickly as possible.

The research is clear: full switchers see major health benefits. Dual users see little to none.

The “Still Vaping” Concern

Remember that NEJM trial where 80% of successful quitters were still vaping at one year? This concerns some health professionals. The goal, they argue, should be complete nicotine abstinence, not switching from one nicotine product to another.

I understand this perspective, but I think it misses the forest for the trees.

If your house is on fire, escaping to the yard is not a failure because you didn’t make it to a five-star hotel. Getting off cigarettes is the urgent priority. Continued vaping at dramatically lower risk buys you time to eventually address nicotine dependence if you choose to.

Many vapers do eventually taper down and quit. They step down nicotine concentrations over months or years, eventually reaching zero nicotine e-liquid, and then stop. The fact that this process takes longer than the 8-12 week NRT timeline doesn’t make it a failure.

Some people vape long-term and never quit nicotine. Is that ideal? No. Is it enormously better than smoking? Absolutely.

Who Should Consider Vaping to Quit

Vaping for cessation makes the most sense if:

You’ve tried traditional NRT (patches, gum) and they didn’t work. The behavioral similarity between vaping and smoking may be the missing piece.
You’re a heavy smoker (pack a day or more) who needs a strong sensory replacement for the smoking ritual.
You want something that addresses both the nicotine craving and the hand-to-mouth habit simultaneously.
You’ve tried varenicline and either couldn’t tolerate the side effects or it didn’t work for you.
You’re motivated to fully switch, not to dual use.

Vaping for cessation might not be the best choice if:

You’re a light or social smoker. Traditional NRT or even cold turkey may be sufficient.
You have serious lung disease and want to avoid any inhalation exposure.
You’re uncomfortable with using a product that lacks FDA cessation approval.
You have a history of substance abuse and are concerned about the reinforcing nature of the hand-to-mouth ritual.
You’re under 21 and not a current smoker. Vaping should not be a starting point. It’s an off-ramp from smoking, not an on-ramp to nicotine.

My Honest Take

The evidence is strong enough that I’m comfortable saying this: vaping works for quitting smoking, and for many people, it works better than traditional NRT. The UK has the right approach. The US position is driven more by politics and fear than by science.

That doesn’t mean vaping is perfect. It’s a harm reduction tool, not a health product. Long-term vaping carries some risks we haven’t fully quantified. The best outcome is to quit smoking, use vaping to bridge the transition, and eventually quit vaping too.

But the best outcome that’s actually achievable for you, right now, is whatever gets you off cigarettes and keeps you off. If that’s vaping, then vaping is the right choice. Don’t let perfect be the enemy of good, and don’t let the US policy confusion stop you from using an evidence-based tool that could save your life.

The cigarettes are the emergency. Everything else is details.